These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3524471)

  • 21. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
    Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
    Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis.
    Anderson L; Schmieder GJ; Werschler WP; Tschen EH; Ling MR; Stough DB; Katsamas J
    J Am Acad Dermatol; 2009 Jun; 60(6):934-43. PubMed ID: 19467365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diclofenac sodium 3% gel in the treatment of actinic keratoses postcryosurgery.
    Berlin JM; Rigel DS
    J Drugs Dermatol; 2008 Jul; 7(7):669-73. PubMed ID: 18664159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prophylactic efficacy of intranasal alpha 2-interferon against rhinovirus infections in the family setting.
    Douglas RM; Moore BW; Miles HB; Davies LM; Graham NM; Ryan P; Worswick DA; Albrecht JK
    N Engl J Med; 1986 Jan; 314(2):65-70. PubMed ID: 3001518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapy with interferon (recombinant IFN-alpha-2C) in myeloproliferative diseases with severe thrombocytoses].
    Linkesch W; Gisslinger H; Ludwig H; Flener R; Sinzinger H
    Acta Med Austriaca; 1985; 12(5):123-7. PubMed ID: 3914173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I study of human leukocyte interferon in patients with advanced cancer.
    Horning SJ; Levine JF; Meyer M; Merigan TC; Rosenberg SA
    J Biol Response Mod; 1983; 2(1):47-56. PubMed ID: 6196450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Actinic keratoses.
    Basler RS; Eberspacher DL
    Nebr Med J; 1989 Jul; 74(7):174-7. PubMed ID: 2761656
    [No Abstract]   [Full Text] [Related]  

  • 28. Actinic keratoses: new treatment options.
    Correale CE
    Adv Dermatol; 2002; 18():339-55. PubMed ID: 12528411
    [No Abstract]   [Full Text] [Related]  

  • 29. A randomized, double-blind, placebo-controlled dose-escalation trial of merimepodib (VX-497) and interferon-alpha in previously untreated patients with chronic hepatitis C.
    McHutchison JG; Shiffman ML; Cheung RC; Gordon SC; Wright TL; Pottage JC; McNair L; Ette E; Moseley S; Alam J
    Antivir Ther; 2005; 10(5):635-43. PubMed ID: 16152757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of recurrent malignant glioma by repeated intracerebral injections of human recombinant interleukin-2 alone or in combination with systemic interferon-alpha. Results of a phase I clinical trial.
    Merchant RE; McVicar DW; Merchant LH; Young HF
    J Neurooncol; 1992 Jan; 12(1):75-83. PubMed ID: 1541981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of recurrent genital herpes simplex virus infection with recombinant alpha 2 interferon.
    Kuhls TL; Sacher J; Pineda E; Santomauro D; Wiesmeier E; Growdon WA; Bryson YJ
    J Infect Dis; 1986 Sep; 154(3):437-42. PubMed ID: 3525695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Results of a phase II study on the treatment of hairy cell leukemias with various doses of alpha-2-recombinant interferon].
    Aulitzky W; Gastl G; Troppmair J; Tilg H; Abbrederis K; Nerl C; Flener R; Rokos H; Huber C
    Acta Med Austriaca; 1985; 12(5):115-21. PubMed ID: 3832745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy of genital herpes with topically applied interferon.
    Eron LJ; Toy C; Salsitz B; Scheer RR; Wood DL; Nadler PI
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1137-9. PubMed ID: 3310870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I/II trial of human recombinant beta-interferon serine in patients with renal cell carcinoma.
    Rinehart J; Malspeis L; Young D; Neidhart J
    Cancer Res; 1986 Oct; 46(10):5364-7. PubMed ID: 3756886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parameters of interferon action: II. Immunological effects of recombinant leukocyte interferon (IFN-alpha 2) in phase I-II trials.
    Ernstoff MS; Fusi S; Kirkwood JM
    J Biol Response Mod; 1983; 2(6):540-7. PubMed ID: 6607324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: a randomized, vehicle-controlled clinical trial.
    Jorizzo J; Weiss J; Furst K; VandePol C; Levy SF
    Arch Dermatol; 2004 Jul; 140(7):813-6. PubMed ID: 15262691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interferon in the treatment of multiple myeloma].
    Kuzmits R; Ludwig H; Cortelezzi A; Van Camp BG; Polli E; Flener R; Scheithauer W
    Acta Med Austriaca; 1985; 12(5):135-8. PubMed ID: 3914174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Managing solar keratoses.
    Drug Ther Bull; 2002 May; 40(5):33-5. PubMed ID: 12053828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Open-label phase II trial of recombinant beta interferon (IFN-beta (ser)) in patients with colorectal cancer.
    Triozzi PL; Kenney P; Young D; Rinehart JJ
    Cancer Treat Rep; 1987 Oct; 71(10):983-4. PubMed ID: 3308083
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of an intralesional sustained-release formulation of interferon alfa-2b on basal cell carcinomas.
    Edwards L; Tucker SB; Perednia D; Smiles KA; Taylor EL; Tanner DJ; Peets E
    Arch Dermatol; 1990 Aug; 126(8):1029-32. PubMed ID: 2383027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.